Current Value of Holding

$0

Shares

0

% of Portfolio

0.00%

Average Buy Price

$17

Avg closing price
Price range

11 Chuck Royce Paratek Pharmaceuticals Trades

The first Paratek Pharmaceuticals trade was made in Q1 2017. Since then Chuck Royce bought shares six more times and sold shares on four occasions. The investor sold all their shares in Q4 2019 and doesn't own any shares in Paratek Pharmaceuticals anymore.

Avg closing price
Price range
Sold -295 Thousand shares Q4 2019
Avg closing price $3.47
Price range $2.93 - $4.50
Increased shares by 24.0% (+57.1 Thousand shares) Q3 2019
Avg closing price $4.00
Price range $3.08 - $5.76
Sold 25.2% shares (-80 Thousand shares) Q2 2019
Avg closing price $4.76
Price range $3.47 - $6.32
Sold 19.4% shares (-76.7 Thousand shares) Q4 2018
Avg closing price $7.59
Price range $4.80 - $11.60
Sold 4.5% shares (-18.5 Thousand shares) Q3 2018
Avg closing price $10.09
Price range $9.05 - $10.95
Increased shares by 6.0% (+23.2 Thousand shares) Q2 2018
Avg closing price $11.32
Price range $10.20 - $13.90
Increased shares by 8.2% (+29.4 Thousand shares) Q1 2018
Avg closing price $14.89
Price range $12.65 - $18.85
Increased shares by 22.9% (+67.1 Thousand shares) Q4 2017
Avg closing price $20.87
Price range $17.45 - $25.60
Increased shares by 3.6% (+10.3 Thousand shares) Q3 2017
Avg closing price $23.28
Price range $18.90 - $28.20
Increased shares by 113.3% (+150 Thousand shares) Q2 2017
Avg closing price $22.11
Price range $18.60 - $25.45
New holding (+133 Thousand shares) Q1 2017
Avg closing price $15.76
Price range $14.25 - $19.25

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!